Akebia Therapeutics: Q4 Earnings Snapshot

CAMBRIDGE, Mass. (AP) — CAMBRIDGE, Mass. (AP) — Akebia Therapeutics Inc. (AKBA) on Thursday reported a loss of $7.6 million in its fourth quarter.

On a per-share basis, the Cambridge, Massachusetts-based company said it had a loss of 4 cents.

The kidney disease treatment developer posted revenue of $55.2 million in the period.

For the year, the company reported that its loss narrowed to $92.6 million, or 51 cents per share. Revenue was reported as $292.6 million.

The company’s shares closed at $1.03. A year ago, they were trading at $2.53.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AKBA at https://www.zacks.com/ap/AKBA

Copyright © 2023 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.

More from WTOP

Log in to your WTOP account for notifications and alerts customized for you.

Sign up